Malignant condition further subdivided into colorectal carcinoma, gastric carcinoma, pancreatic carcinoma
, lung carcinoma, breast carcinoma, ovarian cancer, thyroid cancer and others.
We would like to share a very rare subtype of PDAC, undiferentiated pancreatic carcinoma
with osteoclast-like giant cells (UPC-OGC) presenting as a cystic mass.
Our case was assessed as low grade tumor grade I, with abundant large osteoclast giant cells and background cells with minimal atypia and scant mitoses, in accordance with the histopathological grading based on the scoring system of Netherlands Committee on Bone Tumors , but also as grade 3--poorly differentiated tumor by using the exocrine pancreatic carcinoma
grading from WHO 2010  and as grade 4 according to The American Joint Committee on Cancer staging manual 8th edition .
Association between small intestinal bacterial overgrowth and toll-like receptor 4 in patients with pancreatic carcinoma
Expression of plasminogen activators and their inhibitors in human pancreatic carcinoma
: Immunohistochemical study.
"In models of pancreatic cancer progression, exosomes containing MIF are released in circulation prior to the onset of a recognized pancreatic carcinoma
and can 'educate' the liver, inducing fibrosis," says first author Bruno Costa Silva, an instructor of cell and developmental biology in pediatrics.
We intended to share it with the literature because of the occult pancreatic carcinoma
and its presentation with VTE.
Recent studies also suggest that LMO2 over-expression may be associated with several other malignant tumors, including gastric carcinoma (7), pancreatic carcinoma
(8) and glioma (9).
Moreover, unexpected metastases such as pleomorphic liposarcoma, colon carcinoma, and pancreatic carcinoma
have been reported in the literature (5, 7, 9).
Authors (years) Patients Primary disease Peck and n = 4/66 * Pancreatic carcinoma
Wattam  Female (n = 3) (n = 2); cholangiocarcinoma Male (n = 1) (n = 1); recurrent Age, 78.5 [+ or -] 5.6 cholangitis (n = 1) years Yoshida et 82, male Pancreatic carcinoma
Wieand et al., "A phase III trial on the therapy of advanced pancreatic carcinoma
evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin," Cancer, vol.
Misdiagnosis maybe related to the following factors: (1) the low incidence of pancreatic TB, the lack of specific clinical manifestations, and a clinician's lack of relevant knowledge; (2) the low clinical significance of general laboratory and biochemical/immunological examinations; and (3) the difficulty in diagnosing pancreatic TB by imaging, as patients may present with masses, cystic lesions, or abscesses as well as mass lesions in most cases of pancreatic carcinoma
. The diagnosis of pancreatic TB eventually relies on pathological or microbiological results, including cytology, histology, acid-fast staining, TB culture, and PCR.